Skip to content

Amyotrophic Lateral Sclerosis Registry

Amyotrophic Lateral Sclerosis Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05892822
Enrollment
1000
Registered
2023-06-07
Start date
2023-06-15
Completion date
2024-12-31
Last updated
2023-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Keywords

Amyotrophic lateral sclerosis

Brief summary

This study takes amyotrophic lateral sclerosis (ALS) patients as the main research object. Through collecting genetics, imaging and clinical symptoms for Exploratory research, we will construct the gene spectrum of ALS in China, explore unknown pathogenic genes, explore the characteristic image characteristics of ALS, and establish the iPSCs library of ALS, providing resources and basis for the research of pathogenesis and treatment targets of ALS.

Detailed description

This study is a multicenter, prospective registration study that will follow up patients with clinically confirmed and suspected amyotrophic lateral sclerosis for a period of 2 years. A total of 1000 patients will be included to dynamically observe the changes in clinical symptoms and signs, imaging, electrophysiology, biomarkers, biological samples and so on, which will construct a genetic profile of ALS in China, explore the etiology and pathogenesis, and establish an iPSCs library, provide a basis for finding treatment targets.

Interventions

OTHERAmyotrophic Lateral Sclerosis

All ALS patients included in this group.

Sponsors

yilong Wang
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18 years old ≤ age ≤ 80 years old; * Patients are diagnosed definite or probable ALS according to the Awaji diagnostic criteria; * Sign an informed consent form.

Exclusion criteria

* Unable to cooperate with research or complete follow-up due to geographical or other reasons.

Design outcomes

Primary

MeasureTime frameDescription
Gene Mutation Characteristics of ALS in Chineseday 1Constructing a Chinese ALS genetic information database by collecting genetic information from patients.
The disease development of ALS in the Chinesemonth 24Record the progress of patients' clinical symptoms from baseline through 2-year follow-up.

Secondary

MeasureTime frameDescription
Exploring the imaging characteristics of ALS in the Chineseday 1, month 3, month 6, month 9, month 12, month 15, month 18, month 21, month 24Record the change of the patient's head MRI from baseline through follow-up every 3 months.
Establishing an iPSCs library for ALS in the Chineseday 1100 fALS and clinically typical sALS were selected. Monocytes were isolated from peripheral blood collected at baseline, and Reprogramming into iPSCs to establish iPSCs library.
Analysis of the correlation between electrophysiology characteristics and imaging characteristics of ALS in Chineseday 1, month 3, month 6, month 9, month 12, month 15, month 18, month 21, month 24Record the progression of the disease from an electrophysiological and imaging perspective by conducting electromyography and head MRI every 3 months.

Countries

China

Contacts

Primary ContactYilong Wang, M.D.
yilong528@gmail.com13911666571
Backup ContactWeiqi Chen, M.D.
weiqichen@aliyun.com15652813380

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026